ArticleInternational journal of molecular sciences2025
Circular RNA-Drug Association Prediction Based on Multi-Scale Convolutional Neural Networks and Adversarial Autoencoders.
Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- DMAGCL: A dual-masked adaptive graph contrastive learning framework for predicting circRNA-drug sensitivity.Frontiers in genetics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The prediction of circular RNA (circRNA)-drug associations plays a crucial role in understanding disease mechanisms and identifying potential therapeutic targets. Traditional methods often struggle to cope with the complexity of heterogeneous networks and the high dimensionality of biological data. In this study, we propose a circRNA-drug association prediction method based on multi-scale convolutional neural networks (MSCNN) and adversarial autoencoders, named AAECDA. First, we construct a feature network by integrating circRNA sequence similarity, drug structure similarity, and known circRNA-drug associations. Then, unlike conventional convolutional neural networks, we employ MSCNN to extract hierarchical features from this integrated network. Subsequently, adversarial characteristics are introduced to further refine these features through an adversarial autoencoder, obtaining low-dimensional representations. Finally, the learned representations are fed into a deep neural network to predict novel circRNA-drug associations. Experiments show that AAECDA outperforms various baseline methods in predicting circRNA-drug associations. Additionally, case studies demonstrate that our model is applicable in practical related tasks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.